AVAC Fellow Peter Mogere: HIV self-testing

2017 AVAC Advocacy Fellow Peter Mogere speaks on Kenya’s KUTV about HIV self-testing.

Watch the clip (17:29).

An Advocate’s Guide to Research Terms in the Post-Placebo Era

In Px Wire, AVAC’s quarterly update on HIV prevention design, we presented this illustration on some new types of biomedical prevention trial design. You’ll find a summary of long-acting PrEP trials, a lexicon of key terms for the “post-placebo era”, and a handy illustration for looking smart while you explain “double-dummy double-blind”.

To download just the graphic, without the accompanying text and lexicon, click here: JPG, PDF. For the lexicon only, click here (PDF).

Px Wire October-December 2016, Vol. 9, No. 4

The theme of this year’s World AIDS Day captures the spirit: Hands Up for HIV Prevention. At AVAC, we’re delighted to see the focus on this critical area of the global response. Our new issue of Px Wire provides specifics on some hot topics for advocacy before, on and after World AIDS Day.

Slow and Steady Won’t Win the Prevention Race

Progress in voluntary medical male circumcision has made significant gains but still fell short of targets—or why VMMC isn’t a global priority and how to make it one. Excerpted from AVAC Report 2016: Big Data, Real People.

Programs but Not Yet Platforms: The peril and promise of women’s biomedical HIV prevention in 2016

The benefits of PrEP is winning over support from international bodies and an increasing number of national governments. PrEP introduction is advancing on several fronts, but all this momentum has yet to impact some of the people who need it most, in particular, adolescent girls and young women with high risk of acquiring HIV. Check out our up-close look at the issue from AVAC 2016’s Big Data, Real People.

Breaking the Cycle of Heterosexual Transmission

Excerpted from Px Wire, this is a novel look at how to use today’s tools to break the cycle of heterosexual transmission that was so clearly defined in a major AIDS 2016 presentation.

Biomedical Prevention in 2016 – At a Glance

A snapshot of prevention strategies underway or under development from 2015-2020. Excerpted from AVAC Report 2016: Big Data, Real People.

Broad Data Needs for Women and Girls

There is a serious dearth of data on a range of factors affecting women and girls that must be addressed. Effective programs require data on characteristics such as education, employment, HIV status and health outcomes. Excerpted from AVAC Report 2016: Big Data, Real People.

Demographic Shift in Southern Africa: 10- to 29-year-olds

Early gains in the fight against HIV could be lost if the growing population of young women in sub-Saharan Africa is neglected. Excerpted from AVAC Report 2016 Big Data Real People.

Unnecessary Confusion on Hormonal Contraception and HIV: WHO must act now

The question of whether specific contraceptive methods, particularly the injectable progestogen-only method known as DMPA or Depo-Provera, affect women’s risk of HIV is complex and, for the moment, unanswered. And the WHO has added to the complexit with a layer of completely preventable confusion.

This graphic was excerpted from AVAC Report 2016: Big Data, Real People.